Apixaban
Brand name: Eliquis
Rank #1 of 500 drugs by total cost
$7.75B
Total Cost
8,995,930
Total Claims
$7.75B
Total Cost
109,344
Prescribers
$862
Cost per Claim
1,867,503
Beneficiaries
14,347,700
30-Day Fills
$71K
Avg Cost/Provider
82
Avg Claims/Provider
About Apixaban
Apixaban (sold as Eliquis) was prescribed 8,995,930 times by 109,344 Medicare Part D providers in 2023, costing the program $7.75B. At $862 per claim, this is a high-cost medication.
💰 This drug alone accounts for 2.8% of all Medicare Part D drug spending.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 1 | Apixaban (Eliquis) | $7.75B | 8,995,930 |
| 2 | Semaglutide (Ozempic) | $4.30B | 3,193,643 |
| 3 | Empagliflozin (Jardiance) | $3.58B | 3,334,784 |
| 4 | Dulaglutide (Trulicity) | $2.99B | 2,175,100 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology